Share on StockTwits

Acceleron Pharma (NASDAQ:XLRN) SVP Matthew L. Sherman sold 2,500 shares of the stock on the open market in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $34.42, for a total value of $86,050.00. Following the sale, the senior vice president now directly owns 13,858 shares in the company, valued at approximately $476,992. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Shares of Acceleron Pharma (NASDAQ:XLRN) traded up 1.25% during mid-day trading on Friday, hitting $34.77. The stock had a trading volume of 425,128 shares. Acceleron Pharma has a 52-week low of $16.78 and a 52-week high of $57.89. The stock’s 50-day moving average is $31.98 and its 200-day moving average is $37.93. The company’s market cap is $1.094 billion.

Acceleron Pharma (NASDAQ:XLRN) last released its earnings data on Thursday, May 15th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.14. The company had revenue of $3.31 million for the quarter, compared to the consensus estimate of $2.85 million. Analysts expect that Acceleron Pharma will post $-1.24 EPS for the current fiscal year.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.